Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of EUR 243.38 billion. The enterprise value is 263.04 billion.
| Market Cap | 243.38B |
| Enterprise Value | 263.04B |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Dec 15, 2025 |
Share Statistics
| Current Share Class | 2.48B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.34% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 78.43% |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 15.65.
| PE Ratio | 15.65 |
| Forward PE | n/a |
| PS Ratio | 4.40 |
| PB Ratio | 5.51 |
| P/TBV Ratio | 19.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.92 |
| EV / Sales | 4.78 |
| EV / EBITDA | 10.00 |
| EV / EBIT | 11.60 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 1.33 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 30.93%.
| Return on Equity (ROE) | 37.17% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 30.93% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.14% |
| Revenue Per Employee | 748,241 |
| Profits Per Employee | 210,094 |
| Employee Count | 75,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Merck & Co. has paid 2.39 billion in taxes.
| Income Tax | 2.39B |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +2.72% in the last 52 weeks. The beta is 0.30, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +2.72% |
| 50-Day Moving Average | 89.65 |
| 200-Day Moving Average | 75.87 |
| Relative Strength Index (RSI) | 68.56 |
| Average Volume (20 Days) | 3,094 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, Merck & Co. had revenue of EUR 55.37 billion and earned 15.55 billion in profits. Earnings per share was 6.20.
| Revenue | 55.37B |
| Gross Profit | 45.13B |
| Operating Income | 22.81B |
| Pretax Income | 17.94B |
| Net Income | 15.55B |
| EBITDA | 26.46B |
| EBIT | 22.81B |
| Earnings Per Share (EPS) | 6.20 |
Balance Sheet
The company has 15.51 billion in cash and 35.24 billion in debt, with a net cash position of -19.73 billion.
| Cash & Cash Equivalents | 15.51B |
| Total Debt | 35.24B |
| Net Cash | -19.73B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 44.21B |
| Book Value Per Share | 17.75 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 81.50%, with operating and profit margins of 41.19% and 28.08%.
| Gross Margin | 81.50% |
| Operating Margin | 41.19% |
| Pretax Margin | 32.41% |
| Profit Margin | 28.08% |
| EBITDA Margin | 47.80% |
| EBIT Margin | 41.19% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.86, which amounts to a dividend yield of 2.91%.
| Dividend Per Share | 2.86 |
| Dividend Yield | 2.91% |
| Dividend Growth (YoY) | -1.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.34% |
| Shareholder Yield | 4.25% |
| Earnings Yield | 6.39% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |